A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
PHASE4CompletedINTERVENTIONAL
Enrollment
73
Participants
Timeline
Start Date
December 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
June 30, 2014
Conditions
Cancer
Interventions
DRUG
Targin
Single arm for Targin
Trial Locations (1)
Unknown
Seoul ST.Mary Hospital, Seoul
All Listed Sponsors
lead
Mundipharma Korea Ltd
INDUSTRY
NCT01675531 - A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) | Biotech Hunter | Biotech Hunter